131 related articles for article (PubMed ID: 12068794)
1. Combined therapy in advanced stages (III and IV) of follicular lymphoma increases the possibility of cure: results of a large controlled clinical trial.
Avilés A; Delgado S; Fernández R; Talavera A; Neri N; Huerta-Guzmán J
Eur J Haematol; 2002 Mar; 68(3):144-9. PubMed ID: 12068794
[TBL] [Abstract][Full Text] [Related]
2. Interferon alpha 2b as maintenance therapy improves outcome in follicular lymphoma.
Avilés A; Neri N; Huerta-Guzmán J; Pérez F; Sotelo L
Leuk Lymphoma; 2004 Nov; 45(11):2247-51. PubMed ID: 15512813
[TBL] [Abstract][Full Text] [Related]
3. Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.
Taverna C; Martinelli G; Hitz F; Mingrone W; Pabst T; Cevreska L; Del Giglio A; Vanazzi A; Laszlo D; Raats J; Rauch D; Vorobiof DA; Lohri A; Biaggi Rudolf C; Rondeau S; Rusterholz C; Heijnen IA; Zucca E; Ghielmini M
J Clin Oncol; 2016 Feb; 34(5):495-500. PubMed ID: 26712227
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Morschhauser F; Radford J; Van Hoof A; Vitolo U; Soubeyran P; Tilly H; Huijgens PC; Kolstad A; d'Amore F; Gonzalez Diaz M; Petrini M; Sebban C; Zinzani PL; van Oers MH; van Putten W; Bischof-Delaloye A; Rohatiner A; Salles G; Kuhlmann J; Hagenbeek A
J Clin Oncol; 2008 Nov; 26(32):5156-64. PubMed ID: 18854568
[TBL] [Abstract][Full Text] [Related]
5. Long-term results in patients with low-grade nodular non-Hodgkin's lymphoma. A randomized trial comparing chemotherapy plus radiotherapy with chemotherapy alone.
Avilés A; Díaz-Maqueo JC; Sánchez E; Córtes HD; Ayala JR
Acta Oncol; 1991; 30(3):329-33. PubMed ID: 2036242
[TBL] [Abstract][Full Text] [Related]
6. Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.
Bruna R; Benedetti F; Boccomini C; Patti C; Barbui AM; Pulsoni A; Musso M; Liberati AM; Gini G; Castellino C; Rossini F; Ciceri F; Rota-Scalabrini D; Stelitano C; Di Raimondo F; Tucci A; Devizzi L; Zoli V; Zallio F; Narni F; Dondi A; Parvis G; Semenzato G; Lanza F; Perrone T; Angrilli F; Billio A; Gueli A; Mantoan B; Rambaldi A; Gianni AM; Corradini P; Passera R; Ladetto M; Tarella C
Haematologica; 2019 Nov; 104(11):2241-2248. PubMed ID: 31666344
[TBL] [Abstract][Full Text] [Related]
7. Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score.
Peters AC; Duan Q; Russell JA; Duggan P; Owen C; Stewart DA
Leuk Lymphoma; 2011 Nov; 52(11):2124-9. PubMed ID: 21740097
[TBL] [Abstract][Full Text] [Related]
8. Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma.
Besa PC; McLaughlin PW; Cox JD; Fuller LM
Cancer; 1995 May; 75(9):2361-7. PubMed ID: 7712449
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
Ott OJ; Rödel C; Gramatzki M; Niedobitek G; Sauer R; Grabenbauer GG
Strahlenther Onkol; 2003 Oct; 179(10):694-701. PubMed ID: 14566478
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy plus interferon-alpha2b versus chemotherapy in the treatment of follicular lymphoma.
Neri N; Avilés A; Cleto S; Díaz N; Talavera A; García EL; Díaz-Maqueo JC
J Hematother Stem Cell Res; 2001 Oct; 10(5):669-74. PubMed ID: 11672513
[TBL] [Abstract][Full Text] [Related]
11. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
12. The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases.
Rigacci L; Federico M; Martelli M; Zinzani PL; Cavanna L; Bellesi G; Merli F; Alterini R; Petrucci MT; Tani M; Liberati AM; Vitolo U; Pavone V; Cuneo A; Chisesib T; Brugiatelli M;
Leuk Lymphoma; 2003 Nov; 44(11):1911-7. PubMed ID: 14738142
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome.
Avilés A; Fernándezb R; Pérez F; Nambo MJ; Neri N; Talavera A; Castañeda C; González M; Cleto S
Leuk Lymphoma; 2004 Jul; 45(7):1385-9. PubMed ID: 15359637
[TBL] [Abstract][Full Text] [Related]
14. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma.
Avilés A; Fernández R; Calva A; Neri N; Huerta-Guzmán J; Nambo MJ
Hematology; 2003 Feb; 8(1):7-10. PubMed ID: 12623421
[TBL] [Abstract][Full Text] [Related]
16. Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study.
Herold M; Haas A; Srock S; Neser S; Al-Ali KH; Neubauer A; Dölken G; Naumann R; Knauf W; Freund M; Rohrberg R; Höffken K; Franke A; Ittel T; Kettner E; Haak U; Mey U; Klinkenstein C; Assmann M; von Grünhagen U;
J Clin Oncol; 2007 May; 25(15):1986-92. PubMed ID: 17420513
[TBL] [Abstract][Full Text] [Related]
17. [Follicle centre lymphoma: treatment results for stage I and II].
Neumann H; Blanck H; Koch R; Fiedler S; Lesche A; Herrmann T
Strahlenther Onkol; 2003 Dec; 179(12):840-6. PubMed ID: 14652673
[TBL] [Abstract][Full Text] [Related]
18. Follicular large cell lymphoma: analysis and prognostic factors in 62 patients.
Kantarjian HM; McLaughlin P; Fuller LM; Dixon DO; Osborne BM; Cabanillas FF
J Clin Oncol; 1984 Jul; 2(7):811-9. PubMed ID: 6376721
[TBL] [Abstract][Full Text] [Related]
19. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
Watanabe T; Tobinai K; Wakabayashi M; Morishima Y; Kobayashi H; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Yoshino T; Nawano S; Terauchi T; Hotta T; Nagai H; Tsukasaki K;
Lancet Haematol; 2018 Nov; 5(11):e520-e531. PubMed ID: 30389034
[TBL] [Abstract][Full Text] [Related]
20. Follicular non-Hodgkin's lymphoma: the role of radiation therapy.
Mauch P
Ann Hematol; 2001; 80 Suppl 3():B63-5. PubMed ID: 11757711
[No Abstract] [Full Text] [Related]
[Next] [New Search]